Cell Therapy for IBM by Muscle Injection of ADSVF

NCT05032131 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris